Moderna Inc at Chardan Genetic Medicines Conference (Virtual) Transcript
Hello, and it's now my pleasure to introduce our next fireside chat guest, Dr. Stephen Hoge, President of Moderna. Stephen, thank you again for joining us today.
Questions & Answers
And maybe let's start off by big picture items. So last year, when you participated in our conference, Moderna was a Phase III company, and now millions of people have received the Moderna COVID-19 vaccine. We've seen the pipeline advance, and you've announced a number of research and manufacturing initiatives. So before we talk about these topics in a bit more detail, can you comment at a high level on Moderna's trajectory and priorities going forward?
Well, thank you, and thanks again for having me back. I enjoyed it so much last year and the year before. So this will be an exciting chance to reprise
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |